IGC Pharma, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for IGC, updated each market day.
IGC AI Sentiment
AI sees no strong directional signal for IGC Pharma, Inc. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About IGC Pharma, Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Sector
Exchange
Market Cap
$27,541,499
Cap Tier
Employees
70
Headquarters
POTOMAC, MD
Listed Since
April 13, 2006
Website
IGC Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IGC Volatility
IGC Pharma, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
